Jose Manuel Garcia-Lopez
Research Subjects
Jose Manuel Garcia-Lopez has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Marcos Pazos-Couselo
Faculty of Nursing University of Santiago de Compostela Santiago de Compostela Spain
5 shared publications - Santiago Rodriguez-Segade
Department of Biochemistry and Molecular Biology, University of Santiago de Compostela, Santiago de Compostela, Spain
5 shared publications Felipe Casanueva
Hospital Complex Santiago de Compostela, Endocrinology and Nutrition Service, Santiago de Compostela, Spain; Physiopathology of Obesity and Nutrition Biomedical Research Network Consortium, Santiago de Compostela, Spain
3 shared publicationsA. De La Fuente
2 shared publicationsAlma Prieto-Tenreiro
Section of Endocrinology and Nutrition, Hospital El Bierzo, Ponferrada, Spain
2 shared publicationsFrancisco Gude
Hospital Complex Santiago de Compostela, Clinical Epidemiology Unit, Santiago de Compostela, Spain
2 shared publications
Latest Publications
- Open Access
- 17 December 2021
- Published by Universidad Nacional de La Plata in Relaciones
- Vol. 46 (2) , e020
Dieta humana, movilidad y tecnología en un contexto mortuorio del valle del Atuel: el registro de Cañada Seca-1 (San Rafael, Mendoza)
Este trabajo tiene como objetivo caracterizar el sitio Cañada Seca-1, un entierro múltiple (NMI=24) localizado en el valle del Atuel y fechado en ca. 1500 años AP, a través de la integración de diferentes líneas de evidencia. A partir de este registro se discuten las interpretaciones en torno a la presencia de cultígenos y sus implicancias para la subsistencia humana en un área caracterizada tradicionalmente como el límite de la dispersión agrícola sudamericana, ca. 2200 años AP. Los resultados destacan que los individuos inhumados en el sitio no habrían desarrollado una estrategia fundamentalmente agrícola, aunque el maíz formó parte de su dieta. Además, la nueva información sobre los comportamientos mortuorios en la zona del valle del Atuel, ofrece evidencias tanto sobre movilidad como sobre el uso de tecnologías utilitarias (líticas) y no utilitarias (ornamentos líticos y malacológicos) que trascendieron la vida cotidiana y los acompañaron en la muerte.
- 17 December 2021
- Published by Universidad Nacional de La Plata in Relaciones
- Vol. 46 (2) , e020
Open AccessDieta humana, movilidad y tecnología en un contexto mortuorio del valle del Atuel: el registro de Cañada Seca-1 (San Rafael, Mendoza)
Este trabajo tiene como objetivo caracterizar el sitio Cañada Seca-1, un entierro múltiple (NMI=24) localizado en el valle del Atuel y fechado en ca. 1500 años AP, a través de la integración de diferentes líneas de evidencia. A partir de este registro se discuten las interpretaciones en torno a la presencia de cultígenos y sus implicancias para la subsistencia humana en un área caracterizada tradicionalmente como el límite de la dispersión agrícola sudamericana, ca. 2200 años AP. Los resultados destacan que los individuos inhumados en el sitio no habrían desarrollado una estrategia fundamentalmente agrícola, aunque el maíz formó parte de su dieta. Además, la nueva información sobre los comportamientos mortuorios en la zona del valle del Atuel, ofrece evidencias tanto sobre movilidad como sobre el uso de tecnologías utilitarias (líticas) y no utilitarias (ornamentos líticos y malacológicos) que trascendieron la vida cotidiana y los acompañaron en la muerte.
- Open Access
- 1 December 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5681
Evaluation of a Clinical Pathway for Thyroid Nodular Disease: Timings and Delays in the Diagnosis and Treatment of Thyroid Cancer
Background: Due to the high prevalence of nodular thyroid disease in the general population and the need to rule out malignant tumours, a clinical pathway for nodular thyroid disease was created at our tertiary-level hospital. Our study aimed to quantify timings and delays in diagnosis and treatment in this clinical pathway, specifically for patients who were diagnosed with thyroid cancer. Methods: A retrospective review was conducted of patients who were newly diagnosed with thyroid cancer and who had been previously evaluated in the clinical pathway for nodular thyroid disease at our institution during 2015–2017. Patient demographics, previous diagnostic studies, cytological results, tumour details and key dates were analysed to identify wait times in diagnosis and treatment. Results: Forty patients with thyroid cancer were included. The diagnostic delay had a median time of 60 days, and the treatment delay was dependent on cytopathological results. The main cause for delay in the diagnostic phase was the timing of the thyroid ultrasound performed by the radiology department. In the treatment phase, patients with a cytological result of Bethesda III, V or VI underwent surgery at the suggested time, while those in the Bethesda II or IV category did not. Conclusions: The major delay found in the diagnostic phase was the timing of the thyroid ultrasound performed by the radiology department. We are not suggesting that this step must be eliminated, though the implementation of routine ultrasonography in a thyroid clinic can help identify patients who need more urgent evaluation for fine needle aspiration cytology. In our hospital, decision for surgery is based mainly on the cytopathological report. Imaging studies and/or molecular testing could be considered to reduce treatment delays.
- 1 December 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5681
Open AccessEvaluation of a Clinical Pathway for Thyroid Nodular Disease: Timings and Delays in the Diagnosis and Treatment of Thyroid Cancer
Background: Due to the high prevalence of nodular thyroid disease in the general population and the need to rule out malignant tumours, a clinical pathway for nodular thyroid disease was created at our tertiary-level hospital. Our study aimed to quantify timings and delays in diagnosis and treatment in this clinical pathway, specifically for patients who were diagnosed with thyroid cancer. Methods: A retrospective review was conducted of patients who were newly diagnosed with thyroid cancer and who had been previously evaluated in the clinical pathway for nodular thyroid disease at our institution during 2015–2017. Patient demographics, previous diagnostic studies, cytological results, tumour details and key dates were analysed to identify wait times in diagnosis and treatment. Results: Forty patients with thyroid cancer were included. The diagnostic delay had a median time of 60 days, and the treatment delay was dependent on cytopathological results. The main cause for delay in the diagnostic phase was the timing of the thyroid ultrasound performed by the radiology department. In the treatment phase, patients with a cytological result of Bethesda III, V or VI underwent surgery at the suggested time, while those in the Bethesda II or IV category did not. Conclusions: The major delay found in the diagnostic phase was the timing of the thyroid ultrasound performed by the radiology department. We are not suggesting that this step must be eliminated, though the implementation of routine ultrasonography in a thyroid clinic can help identify patients who need more urgent evaluation for fine needle aspiration cytology. In our hospital, decision for surgery is based mainly on the cytopathological report. Imaging studies and/or molecular testing could be considered to reduce treatment delays.
- Open Access
- 17 July 2019
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 16 (1) , 1-9
Postprandial glycemic response in a non-diabetic adult population: the effect of nutrients is different between men and women
There is a growing interest in the pathopysiological consequences of postprandial hyperglycemia. It is well known that in diabetic patients 2 h plasma glucose is a better risk predictor for coronary heart disease than fasting plasma glucose. Data on the glycemic response in healthy people are scarce. To evaluate the effect of macronutrients (carbohydrates, fats, and proteins) and fiber on postprandial glycemic response in an observational study of a non-diabetic adult population. Cross-sectional study. 150 non-diabetic adults performed continuous glucose monitoring for 6 days. During this period they recorded food and beverage intake. The participants were instructed not to make changes in their usual diet and physical exercise. Variables analyzed included clinical parameters (age, sex, body weight, height, body mass index, blood pressure, and waist measurement), meal composition (calories, carbohydrates, fats, proteins, and fiber) and glycemic postprandial responses separated by sexes. The study period was defined from the start of dinner to 6 h later. A total of 148 (51% women) subjects completed all study procedures. Dinner intake was higher in males than in females (824 vs 531 kcal). Macronutrient distribution was similar in both sexes. No significant differences were found in fiber intake between men and women (5.5 g vs 4.5 g). In both sexes, the higher intake of carbohydrates corresponded to a significantly higher glycemic response (p = 0.0001 in women, p = 0.022 in men). Moreover, in women, as fat intake was higher, a flattening of the postprandial glycemic curve was observed (p = 0.003). With respect to fiber, a significantly lower glycemic response was observed in the group of women whose fiber intake at dinner was higher (p = 0.034). Continuous glucose monitoring provides important information about glucose levels after meals. In this study, the postprandial glycemic response in women was different from that of men, and carbohydrates were the main determinant of elevated postprandial glucose levels.
- 17 July 2019
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 16 (1) , 1-9
Open AccessPostprandial glycemic response in a non-diabetic adult population: the effect of nutrients is different between men and women
There is a growing interest in the pathopysiological consequences of postprandial hyperglycemia. It is well known that in diabetic patients 2 h plasma glucose is a better risk predictor for coronary heart disease than fasting plasma glucose. Data on the glycemic response in healthy people are scarce. To evaluate the effect of macronutrients (carbohydrates, fats, and proteins) and fiber on postprandial glycemic response in an observational study of a non-diabetic adult population. Cross-sectional study. 150 non-diabetic adults performed continuous glucose monitoring for 6 days. During this period they recorded food and beverage intake. The participants were instructed not to make changes in their usual diet and physical exercise. Variables analyzed included clinical parameters (age, sex, body weight, height, body mass index, blood pressure, and waist measurement), meal composition (calories, carbohydrates, fats, proteins, and fiber) and glycemic postprandial responses separated by sexes. The study period was defined from the start of dinner to 6 h later. A total of 148 (51% women) subjects completed all study procedures. Dinner intake was higher in males than in females (824 vs 531 kcal). Macronutrient distribution was similar in both sexes. No significant differences were found in fiber intake between men and women (5.5 g vs 4.5 g). In both sexes, the higher intake of carbohydrates corresponded to a significantly higher glycemic response (p = 0.0001 in women, p = 0.022 in men). Moreover, in women, as fat intake was higher, a flattening of the postprandial glycemic curve was observed (p = 0.003). With respect to fiber, a significantly lower glycemic response was observed in the group of women whose fiber intake at dinner was higher (p = 0.034). Continuous glucose monitoring provides important information about glucose levels after meals. In this study, the postprandial glycemic response in women was different from that of men, and carbohydrates were the main determinant of elevated postprandial glucose levels.
- 21 May 2019
- Published by Springer Nature in Acta Diabetologica
- Vol. 56 (9) , 1023-1030
Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence
To investigate, in a sample of nondiabetic adults from a Spanish community, the differences between prediabetes as defined by HbA1c (“H-prediabetes”) and by fasting plasma glucose (FPG) (“F-prediabetes”) in regard to prevalence and the influence of potential risk factors, adjusting the latter for confounders.
- 21 May 2019
- Published by Springer Nature in Acta Diabetologica
- Vol. 56 (9) , 1023-1030
Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence
To investigate, in a sample of nondiabetic adults from a Spanish community, the differences between prediabetes as defined by HbA1c (“H-prediabetes”) and by fasting plasma glucose (FPG) (“F-prediabetes”) in regard to prevalence and the influence of potential risk factors, adjusting the latter for confounders.
- 1 December 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 65 (10) , 556-563
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
- 1 December 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 65 (10) , 556-563
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
- 1 December 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 65 (10) , 556-563
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
- 1 December 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 65 (10) , 556-563
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
- 26 October 2014
- Published by Springer Nature in Acta Diabetologica
- Vol. 52 (3) , 453-459
Influence of the glycation gap on the diagnosis of type 2 diabetes
The results of using HbA1C-based criteria for diagnosis of type 2 diabetes and prediabetes have been reported to differ from those obtained using fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT). We aimed to determine whether these discrepancies might be due to the influence of the glycation gap. For 430 patients without previously diagnosed diabetes for whom an OGTT had been requested in normal clinical practice, FPG, fructosamine and HbA1C were measured at the time of the test and again 1 month later. Glycaemia/diabetes status was classified as normoglycaemia, prediabetes or diabetes using both HbA1C-based and FPG/OGTT-based criteria, and their glycation gaps GG were calculated. The specificity of an HbA1C level of 6.5 % (48 mmol/mol) for diagnosis of FPG/OGTT-defined type 2 diabetes was 99 %, but its sensitivity was less than 37 %. HbA1C-diabetic patients had higher average blood glucose levels than FPG/OGTT-diabetic patients. With either set of criteria, high-GG patients were disproportionately numerous among those classified as diabetic and were disproportionately infrequent among those classified as normoglycaemic, but the effect was greater for the HbA1C criteria. The differences between HbA1C-based and FPG/OGTT-based diagnoses are largely due to the influence of the glycation gap, which may also influence the early stages of FPG/OGTT-defined diabetes.
- 26 October 2014
- Published by Springer Nature in Acta Diabetologica
- Vol. 52 (3) , 453-459
Influence of the glycation gap on the diagnosis of type 2 diabetes
The results of using HbA1C-based criteria for diagnosis of type 2 diabetes and prediabetes have been reported to differ from those obtained using fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT). We aimed to determine whether these discrepancies might be due to the influence of the glycation gap. For 430 patients without previously diagnosed diabetes for whom an OGTT had been requested in normal clinical practice, FPG, fructosamine and HbA1C were measured at the time of the test and again 1 month later. Glycaemia/diabetes status was classified as normoglycaemia, prediabetes or diabetes using both HbA1C-based and FPG/OGTT-based criteria, and their glycation gaps GG were calculated. The specificity of an HbA1C level of 6.5 % (48 mmol/mol) for diagnosis of FPG/OGTT-defined type 2 diabetes was 99 %, but its sensitivity was less than 37 %. HbA1C-diabetic patients had higher average blood glucose levels than FPG/OGTT-diabetic patients. With either set of criteria, high-GG patients were disproportionately numerous among those classified as diabetic and were disproportionately infrequent among those classified as normoglycaemic, but the effect was greater for the HbA1C criteria. The differences between HbA1C-based and FPG/OGTT-based diagnoses are largely due to the influence of the glycation gap, which may also influence the early stages of FPG/OGTT-defined diabetes.
- Open Access
- 19 June 2014
- Published by MedCrave Group Kft. in Journal of Diabetes, Metabolic Disorders & Control
- Vol. 1 (2)
Optimal Time for Capillary Blood Glucose Monitoring in Patients with Type 2 Diabetes Treated with Insulin: A Cross-Sectional Observation Study
- 19 June 2014
- Published by MedCrave Group Kft. in Journal of Diabetes, Metabolic Disorders & Control
- Vol. 1 (2)
Open AccessOptimal Time for Capillary Blood Glucose Monitoring in Patients with Type 2 Diabetes Treated with Insulin: A Cross-Sectional Observation Study
- 1 February 2013
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 15 (2) , 166-171
Should the Amounts of Fat and Protein Be Taken into Consideration to Calculate the Lunch Prandial Insulin Bolus? Results from a Randomized Crossover Trial
Background: Concerning continuous subcutaneous insulin infusion (CSII), there are controversial results related to changes in glycemic response according to the meal composition and bolus design. Our aim is to determine whether the presence of protein and fat in a meal could involve a different postprandial glycemic response than that obtained with only carbohydrates (CHs). Subjects and Methods: This was a crossover, randomized clinical trial. Seventeen type 1 diabetes (T1D) patients on CSII wore a blinded continuous glucose monitoring system sensor for 3 days. They ingested two meals (meal 1 vs. meal 2) with the same CH content (50 g) but different fat (8.9 g vs. 37.4 g) and protein (3.3 g vs. 28.9 g) contents. A single-wave insulin bolus was used, and the interstitial glucose values were measured every 30 min for 3 h. We evaluated the different postprandial glycemic response between meal 1 and meal 2 by using mixed-effects models. Results: The postmeal glucose increase was 22 mg/dL for meal 1 and 31 mg/dL for meal 2. In univariate analysis, at different times not statistically significant differences in glucose levels between meals occurred. In mixed-model analysis, a time×meal interaction was found, indicating a different response between treatments along the time. However, most of the patients remained in the normoglycemic range (70–180 mg/dL) during the 3-h postmeal period (84.4% for meal 1 and 93.1% for meal 2). Conclusions: The presence of balanced amounts of protein and fat determined a different glycemic response from that obtained with only CH up to 3 h after eating. The clinical relevance of this finding remains to be elucidated.
- 1 February 2013
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 15 (2) , 166-171
Should the Amounts of Fat and Protein Be Taken into Consideration to Calculate the Lunch Prandial Insulin Bolus? Results from a Randomized Crossover Trial
Background: Concerning continuous subcutaneous insulin infusion (CSII), there are controversial results related to changes in glycemic response according to the meal composition and bolus design. Our aim is to determine whether the presence of protein and fat in a meal could involve a different postprandial glycemic response than that obtained with only carbohydrates (CHs). Subjects and Methods: This was a crossover, randomized clinical trial. Seventeen type 1 diabetes (T1D) patients on CSII wore a blinded continuous glucose monitoring system sensor for 3 days. They ingested two meals (meal 1 vs. meal 2) with the same CH content (50 g) but different fat (8.9 g vs. 37.4 g) and protein (3.3 g vs. 28.9 g) contents. A single-wave insulin bolus was used, and the interstitial glucose values were measured every 30 min for 3 h. We evaluated the different postprandial glycemic response between meal 1 and meal 2 by using mixed-effects models. Results: The postmeal glucose increase was 22 mg/dL for meal 1 and 31 mg/dL for meal 2. In univariate analysis, at different times not statistically significant differences in glucose levels between meals occurred. In mixed-model analysis, a time×meal interaction was found, indicating a different response between treatments along the time. However, most of the patients remained in the normoglycemic range (70–180 mg/dL) during the 3-h postmeal period (84.4% for meal 1 and 93.1% for meal 2). Conclusions: The presence of balanced amounts of protein and fat determined a different glycemic response from that obtained with only CH up to 3 h after eating. The clinical relevance of this finding remains to be elucidated.